MAPT and Alzheimer disease: AD is tentatively diagnosed on the basis of a set of clinical symptoms (progressive irreversible decline in memory and other cognitive functions) and confirmed by neuropathology (brain atrophy accompanied by the accumulation of abundant extracellular amyloid β plaques and intraneuronal neurofibrillary tau lesions) [1] (Fig. 1a).